R331W Missense Mutation of Oncogene YAP1 Is a Germline Risk Allele for Lung Adenocarcinoma With Medical Actionability
-
Published:2015-07-10
Issue:20
Volume:33
Page:2303-2310
-
ISSN:0732-183X
-
Container-title:Journal of Clinical Oncology
-
language:en
-
Short-container-title:JCO
Author:
Chen Hsuan-Yu1, Yu Sung-Liang1, Ho Bing-Ching1, Su Kang-Yi1, Hsu Yi-Chiung1, Chang Chi-Sheng1, Li Yu-Cheng1, Yang Shi-Yi1, Hsu Pin-Yen1, Ho Hao1, Chang Ya-Hsuan1, Chen Chih-Yi1, Yang Hwai-I1, Hsu Chung-Ping1, Yang Tsung-Ying1, Chen Kun-Chieh1, Hsu Kuo-Hsuan1, Tseng Jeng-Sen1, Hsia Jiun-Yi1, Chuang Cheng-Yen1, Yuan Shinsheng1, Lee Mei-Hsuan1, Liu Chia-Hsin1, Wu Guan-I1, Hsiung Chao A.1, Chen Yuh-Min1, Wang Chih-Liang1, Huang Ming-Shyan1, Yu Chong-Jen1, Chen Kuan-Yu1, Tsai Ying-Huang1, Su Wu-Chou1, Chen Huei-Wen1, Chen Jeremy J.W.1, Chen Chien-Jen1, Chang Gee-Chen1, Yang Pan-Chyr1, Li Ker-Chau1
Affiliation:
1. Hsuan-Yu Chen, Yi-Chiung Hsu, Chi-Sheng Chang, Yu-Cheng Li, Hao Ho, Ya-Hsuan Chang, Shinsheng Yuan, Chia-Hsin Liu, Guan-I Wu, and Ker-Chau Li, Institute of Statistical Science, and Shi-Yi Yang, Hwai-I Yang, and Chien-Jen Chen, Genomics Research Center, Academia Sinica; Hsuan-Yu Chen, Sung-Liang Yu, Bing-Ching Ho, Kang-Yi Su, and Pin-Yen Hsu, College of Medicine; Hsuan-Yu Chen, College of Life Science; Sung-Liang Yu, Kang-Yi Su, and Pan-Chyr Yang, Center of Genomic Medicine; Huei-Wen Chen, Graduate...
Abstract
Purpose Adenocarcinoma is the most dominant type of lung cancer in never-smoker patients. The risk alleles from genome-wide association studies have small odds ratios and unclear biologic roles. Here we have taken an approach featuring suitable medical actionability to identify alleles with low population frequency but high disease-causing potential. Patients and Methods Whole-genome sequencing was performed for a family with an unusually high density of lung adenocarcinoma with available DNA from the affected mother, four affected daughters, and one nonaffected son. Candidate risk alleles were confirmed by matrix-assisted laser desorption ionization time of flight mass spectroscopy. Validation was conducted in an external cohort of 1,135 participants without cancer and 1,312 patients with lung adenocarcinoma. Family follow-ups were performed by genotyping the relatives of the original proband and the relatives of the identified risk-allele carriers. Low-dose computed tomography scans of the chest were evaluated for lung abnormalities. Results YAP1 R331W missense mutation from the original family was identified and validated in the external controls and the cohort with lung adenocarcinoma. The YAP1 mutant-allele carrier frequency was 1.1% in patients with lung adenocarcinoma compared with 0.18% in controls (P = .0095), yielding an odds ratio (adjusted for age, sex, and smoking status) of 5.9. Among the relatives, YAP1-mutant carriers have overwhelmingly higher frequencies of developing lung adenocarcinoma or ground-glass opacity lung lesions than those who do not carry the mutation (10:0 v 1:7; P < .001). YAP1 mutation was shown to increase the colony formation ability and invasion potential of lung cancer cells. Conclusion These results implicated YAP1 R331W as an allele predisposed for lung adenocarcinoma with high familial penetrance. Low-dose computed tomography scans may be recommended to this subpopulation, which is at high risk for lung cancer, for personalized prevention and health management.
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Cited by
79 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|